Will IMAC Holdings (USA Stocks:BACK) turn things around in September?

IMAC Holdings is a company operating in the healthcare sector, specifically focusing on health care equipment and services. With a market capitalization of approximately $2.8 million, it has been navigating a challenging financial landscape, reporting a loss of $6.5 million before tax and an EBITDA loss of $1.7 million. Despite these hurdles, the company generated $8.5 million in revenue, indicating potential for growth in a market that is always in demand. Investors may find interest in the stock as it currently trades around $1.62, with Wall Street setting a target price of $8.25. As IMAC Holdings continues to develop its offerings, the question remains: can it turn its financial situation around and unlock its true potential? For more information, visit [IMAC Holdings](https://www.imacholdings.com). Currently, IMAC Holdings is showing a stable return on equity compared to last year. The company's net debt to EBITDA ratio is projected to increase to 0.09 this year, while the price-to-sales ratio is likely to decrease to 0.45. With conservative investors increasingly eyeing the healthcare equipment and supplies sector, IMAC Holdings deserves your attention. We will explore why recent price movements suggest a potential rebound in September. This discussion will highlight key fundamental factors influencing IMAC Holdings' products and services and how these may shape the investment outlook for the company in the coming month.
Published over six months ago
View all stories for IMAC Holdings | View All Stories
Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.

Reviewed by Michael Smolkin

About 12% of IMAC Holdings' shares are owned by insiders. This insider ownership includes shares held by company officers, directors, their family members, and others who have access to confidential information before it’s released to the public. For a deeper look into IMAC Holdings, including the latest insights on its ownership structure, be sure to check out our recent analysis.

Main Ideas

IMAC Holdings is making strides in the healthcare sector, particularly in medical care facilities, which positions it well for future growth. Despite facing challenges, including a net income loss of 14.9M, the company’s recent price action shows a slight increase of 0.02, suggesting potential investor interest. With a typical price hovering around 1.63, there may be opportunities for savvy investors to capitalize on its recovery trajectory as it navigates the evolving healthcare landscape.
The performance of IMAC Holdings in the marketplace will significantly impact your decision to invest in its stock. Revenue growth, profitability, competitive positioning, management quality, and industry trends can influence IMAC Holdings' stock prices. When investing in IMAC Holdings, there are several factors to consider and potential outcomes to expect. As a company performs well, its stock price may increase, allowing investors to benefit from price appreciation. However, IMAC Stock can experience significant price fluctuations due to market conditions, economic factors, industry trends, or company-specific news. This is why investing in stocks such as IMAC Holdings carries risks, including the potential for capital loss. Stock prices can decline, and investors may incur losses if they sell shares at a lower price than their initial investment.

Watch out for price decline

Please consider monitoring IMAC Holdings on a daily basis if you are holding a position in it. IMAC Holdings is trading at a penny-stock level, and the possibility of delisting is much higher compared to other stocks. However, just because the stock is trading under one dollar, does not mean it will be marked for deletion. Most exchanges require public instruments, such as IMAC Holdings stock to be traded above the $1 level to remain listed. If IMAC Holdings stock price falls below $1 for 30 consecutive trading days, the exchange can delist it. Once the company reaches this point, they will be sent an initial price violation notice directly from an exchange.

How important is IMAC Holdings's Liquidity

IMAC Holdings financial leverage refers to using borrowed capital as a funding source to finance IMAC Holdings ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. IMAC Holdings financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to IMAC Holdings' owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of IMAC Holdings' financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the breakdown between IMAC Holdings's total debt and its cash.

Is IMAC Holdings valued adequately by the market?

IMAC Holdings owns 12.15 % of its outstanding shares held by insiders and 8.66 % owned by institutions.
 2021 2022 2023 2024 (projected)
Gross Profit12.8M14.7M4.8M8.6M
Total Revenue14.4M16.2M5.2M9.8M

Ownership Breakdown

Retail Investors
79.19%
Insiders
12.15%
Institutions
8.66%
Retail Investors79.19
Insiders12.15
Institutions8.66
In the world of investing, potential often lies beneath the surface. IMAC Holdings, a player in the health care equipment sector, is currently navigating challenging waters, with a net income loss of 6.5 million and an EBITDA loss of 1.7 million.
Despite these hurdles, the company boasts a market capitalization of 2.82 million and a current ratio of 1.18, indicating some liquidity to support operations. With a target price of 8.25, there’s a potential upside of 10.26, suggesting that investors might find value if the company can turn its fortunes around. However, the high probability of bankruptcy at 96% raises significant concerns, making this a high-risk investment for those willing to take a chance on its recovery..

Will price continue to rise in September 2024?

IMAC Holdings has recently experienced significant stock price swings, with a volatility level of 39.76. This suggests that investors are reacting strongly to news and market conditions related to the company. Looking ahead to September 2024, it’s uncertain whether this momentum will lead to a lasting price increase. If positive earnings reports or strategic partnerships emerge, IMAC's stock could rise. However, potential investors should stay alert to market trends and company news.
The current volatility indicates that understanding market fluctuations can help investors make informed decisions. In bear markets, increased volatility can pressure IMAC's stock price, prompting investors to adjust their portfolios as they navigate falling prices.Investing in IMAC Holdings could present a compelling opportunity for those looking to tap into a growth story. With a strong buy consensus from analysts and a projected target price that could reach as high as 38.3, the potential for significant upside is evident. Despite the current EPS estimate of -3.48 for the next year, the company's real value stands at 9.84, suggesting that it may be undervalued in the market. As IMAC Holdings continues to develop its offerings, the combination of strategic growth initiatives and a favorable analyst outlook could make this stock an intriguing option for investors willing to take on some risk for the chance of substantial rewards..

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Editorial Staff

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Rifka Kats do not own shares of IMAC Holdings. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to [email protected]